[DPHARMA] YoY Cumulative Quarter Result on 30-Jun-2015 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
25-Aug-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Jun-2015 [#2]
Profit Trend
QoQ- 65.2%
YoY- -6.76%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Revenue 257,250 240,355 158,605 101,907 81,118 75,826 70,412 24.09%
PBT 26,170 24,764 17,664 20,605 21,302 21,963 17,906 6.52%
Tax -5,184 -5,559 -5,895 -5,788 -5,410 -4,575 -4,331 3.04%
NP 20,986 19,205 11,769 14,817 15,892 17,388 13,575 7.52%
-
NP to SH 20,986 19,217 12,346 14,817 15,892 17,388 13,575 7.52%
-
Tax Rate 19.81% 22.45% 33.37% 28.09% 25.40% 20.83% 24.19% -
Total Cost 236,264 221,150 146,836 87,090 65,226 58,438 56,837 26.78%
-
Net Worth 209,983 463,071 446,334 190,284 179,045 187,340 162,400 4.37%
Dividend
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Div 4,199 6,973 6,973 5,596 5,551 5,550 4,858 -2.39%
Div Payout % 20.01% 36.29% 56.49% 37.77% 34.93% 31.92% 35.79% -
Equity
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Net Worth 209,983 463,071 446,334 190,284 179,045 187,340 162,400 4.37%
NOSH 650,902 278,959 278,959 139,915 138,794 138,770 138,803 29.36%
Ratio Analysis
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
NP Margin 8.16% 7.99% 7.42% 14.54% 19.59% 22.93% 19.28% -
ROE 9.99% 4.15% 2.77% 7.79% 8.88% 9.28% 8.36% -
Per Share
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
RPS 91.88 86.16 56.86 72.83 58.44 54.64 50.73 10.40%
EPS 3.22 6.88 4.22 10.59 11.45 12.53 9.78 -16.89%
DPS 1.50 2.50 2.50 4.00 4.00 4.00 3.50 -13.16%
NAPS 0.75 1.66 1.60 1.36 1.29 1.35 1.17 -7.14%
Adjusted Per Share Value based on latest NOSH - 139,570
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
RPS 26.74 24.99 16.49 10.59 8.43 7.88 7.32 24.08%
EPS 2.18 2.00 1.28 1.54 1.65 1.81 1.41 7.52%
DPS 0.44 0.72 0.72 0.58 0.58 0.58 0.51 -2.42%
NAPS 0.2183 0.4814 0.464 0.1978 0.1861 0.1948 0.1688 4.37%
Price Multiplier on Financial Quarter End Date
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Date 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 28/06/13 29/06/12 -
Price 1.30 2.25 2.04 2.65 2.97 2.38 2.23 -
P/RPS 1.41 2.61 3.59 3.64 5.08 4.36 4.40 -17.26%
P/EPS 17.34 32.66 46.09 25.02 25.94 18.99 22.80 -4.45%
EY 5.77 3.06 2.17 4.00 3.86 5.26 4.39 4.65%
DY 1.15 1.11 1.23 1.51 1.35 1.68 1.57 -5.05%
P/NAPS 1.73 1.36 1.28 1.95 2.30 1.76 1.91 -1.63%
Price Multiplier on Announcement Date
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Date 26/11/18 25/08/17 22/08/16 25/08/15 26/08/14 28/08/13 16/08/12 -
Price 1.08 2.03 2.14 2.40 3.37 2.44 2.38 -
P/RPS 1.18 2.36 3.76 3.30 5.77 4.47 4.69 -20.53%
P/EPS 14.41 29.47 48.35 22.66 29.43 19.47 24.34 -8.36%
EY 6.94 3.39 2.07 4.41 3.40 5.14 4.11 9.11%
DY 1.39 1.23 1.17 1.67 1.19 1.64 1.47 -0.92%
P/NAPS 1.44 1.22 1.34 1.76 2.61 1.81 2.03 -5.56%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment